FTA Standards Development Program: Over-the-Counter and Prescription Drug Use in the Public Transit Industry (Report 0217)
This report includes background research and analysis on the need for new standards, recommended practices, guidance documents, or procedural considerations in the areas of prescription (Rx) and over-the-counter (OTC) medication risk management.
Last updated: Friday, June 3, 2022
DOT is committed to ensuring that information is available in appropriate alternative formats to meet the requirements of persons who have a disability. If you require an alternative version of files provided on this page, please contact FTAWebAccessibility@dot.gov.